外科理论与实践 ›› 2023, Vol. 28 ›› Issue (02): 104-109.doi: 10.16139/j.1007-9610.2023.02.04
收稿日期:
2023-01-29
出版日期:
2023-03-25
发布日期:
2023-06-06
通讯作者:
李相成,E-mail:
LI Xiangcheng(), CHEN Yananlan, LI Changxian
Received:
2023-01-29
Online:
2023-03-25
Published:
2023-06-06
摘要:
根治性手术切除是治愈肝门部胆管癌的唯一治疗选择。镜下胆管切缘阴性(R0切除)对病人长期生存至关重要。然而,因肝门部胆管癌常合并门静脉、肝动脉浸润,无法得到阴性切缘。联合血管切除重建为解决这一难题提供了可能。目前,合并门静脉及肝动脉切除重建的临床价值已得到充分的肯定。本文论述肝门部胆管癌根治术中的门静脉、肝动脉重建技术及其临床价值,术前影像学评估和术后并发症。
中图分类号:
李相成, 陈妍安澜, 李长贤. 肝门部胆管癌根治性切除术中的血管重建技术[J]. 外科理论与实践, 2023, 28(02): 104-109.
LI Xiangcheng, CHEN Yananlan, LI Changxian. Vascular reconstruction in radical resection for hilar cholangiocarcinoma[J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 104-109.
[1] |
KHAN S A, DAVIDSON B R, GOLDIN R D, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update[J]. Gut, 2012, 61(12):1657-1669.
doi: 10.1136/gutjnl-2011-301748 pmid: 22895392 |
[2] |
BANALES J M, MARIN J J G, LAMARCA A, et al. Cho-langiocarcinoma 2020: the next horizon in mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(9):557-588.
doi: 10.1038/s41575-020-0310-z |
[3] |
ITO F, CHO C S, RIKKERS L F, et al. Hilar cholangiocarcinoma: current management[J]. Ann Surg, 2009, 250(2):210-218.
doi: 10.1097/SLA.0b013e3181afe0ab pmid: 19638920 |
[4] |
LAUTERIO A, DE CARLIS R, CENTONZE L, et al. Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma[J]. Cancers (Basel), 2021, 13(15):3657.
doi: 10.3390/cancers13153657 URL |
[5] |
ANGELICO R, SENSI B, PARENTE A, et al. Vascular involvements in cholangiocarcinoma: tips and tricks[J]. Cancers (Basel), 2021, 13(15):3735.
doi: 10.3390/cancers13153735 URL |
[6] |
MUELLER M, BREUER E, MIZUNO T, et al. Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers[J]. Ann Surg, 2021, 274(5):780-788.
doi: 10.1097/SLA.0000000000005103 URL |
[7] |
MIZUNO T, EBATA T, YOKOYAMA Y, et al. Combined vascular resection for locally advanced perihilar cholangiocarcinoma[J]. Ann Surg, 2022, 275(2):382-390.
doi: 10.1097/SLA.0000000000004322 URL |
[8] |
SAPISOCHIN G, IVANICS T, SUBRAMANIAN V, et al. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: a review of the general principles[J]. Int J Surg, 2020, 82S:77-81.
doi: 10.1016/j.ijsu.2020.04.067 pmid: 32380231 |
[9] |
CHEN R X, LI C X, LUO C H, et al. Surgical strategies for the treatment of bismuth type Ⅰ and Ⅱ hilar cholangiocarcinoma: bile duct resection with or without hepatectomy?[J]. Ann Surg Oncol, 2020, 27(9):3374-3382.
doi: 10.1245/s10434-020-08453-2 |
[10] |
DE BELLIS M, MASTROSIMINI M G, CONCI S, et al. The prognostic role of true radical resection in perihilar cholangiocarcinoma after improved evaluation of radial margin status[J]. Cancers (Basel), 2022, 14(24):6126.
doi: 10.3390/cancers14246126 URL |
[11] |
MIZUNO T, EBATA T, NAGINO M. Advanced hilar cholangiocarcinoma: an aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: perioperative management, extended procedures, and multidisciplinary approaches[J]. Surg Oncol, 2020, 33:201-206.
doi: S0960-7404(19)30243-9 pmid: 31301935 |
[12] |
SHE W H, CHEUNG T T, MA K W, et al. Vascular resection and reconstruction in hilar cholangiocarcinoma[J]. ANZ J Surg, 2020, 90(9):1653-1659.
doi: 10.1111/ans.15969 pmid: 32458528 |
[13] |
HIGUCHI R, YAZAWA T, UEMURA S. et al. Surgical outcomes for perihilar cholangiocarcinoma with vascular invasion[J]. J Gastrointest Surg, 2019, 23(7):1443-1453.
doi: 10.1007/s11605-018-3948-x pmid: 30203230 |
[14] |
GOVIL S, REDDY M S, RELA M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma[J]. Langenbecks Arch Surg, 2014, 399(6):707-716.
doi: 10.1007/s00423-014-1216-4 URL |
[15] |
CHO M S, KIM S H, PARK S W, et al. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience[J]. J Gastrointest Surg, 2012, 16(9):1672-1679.
doi: 10.1007/s11605-012-1960-0 pmid: 22798185 |
[16] |
NUZZO G, GIULIANTE F, ARDITO F, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients[J]. Arch Surg, 2012, 147(1):26-34.
doi: 10.1001/archsurg.2011.771 pmid: 22250108 |
[17] | KAJITANI T, KUNO K, HISHIDA Y, et al. Surgery of bile duct cancer at the porta hepatis[J]. Shujutsu, 1966, 20(11):997-1002. |
[18] | 周宁新, 黄志强, 刘永雄, 等. 肝外胆道癌全国调查1 098例分析[J]. 中华外科杂志, 1990, 28(9):516-521. |
ZHOU N X, HUANG Z Q, LIU Y X, et al. A national survey of 1 098 cases of extrahepatic biliary tract carcinoma[J]. Chin J Surg, 1990, 28(9):516-521. | |
[19] |
KURIYAMA N, KOMATSUBARA H, NAKAGAWA Y, et al. Impact of combined vascular resection and reconstruction in patients with advanced perihilar cholangiocarcinoma[J]. J Gastrointest Surg, 2021, 25(12):3108-3118.
doi: 10.1007/s11605-021-05004-2 pmid: 33884578 |
[20] |
NAGINO M, EBATA T, YOKOYAMA Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections[J]. Ann Surg, 2013, 258(1):129-140.
doi: 10.1097/SLA.0b013e3182708b57 pmid: 23059502 |
[21] |
DE JONG M C, MARQUES H, CLARY B M, et al. The impact of portal vein resection on outcomes for hilar cho-langiocarcinoma: a multi-institutional analysis of 305 cases[J]. Cancer, 2012, 118(19):4737-4747.
doi: 10.1002/cncr.27492 URL |
[22] |
MATSUYAMA R, MORI R, OTA Y, et al. Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma: with special reference to hepatic arterial resection and reconstruction[J]. Ann Surg Oncol, 2016, 23(Suppl 4):475-484.
doi: 10.1245/s10434-016-5381-2 URL |
[23] |
TAMOTO E, HIRANO S, TSUCHIKAWA T, et al. Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma[J]. HPB (Oxford), 2014, 16(1):56-61.
doi: 10.1111/hpb.12067 URL |
[24] |
SONG Y, ZHANG Y, ZHEN Z, et al. Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis[J]. World J Surg Oncol, 2022, 20(1):230.
doi: 10.1186/s12957-022-02692-1 pmid: 35821140 |
[25] |
OTA T, ARAIDA T, YAMAMOTO M, et al. Operative outcome and problems of right hepatic lobectomy with pancreatoduodenectomy for advanced carcinoma of the biliary tract[J]. J Hepatobiliary Pancreat Surg, 2007, 14(2):155-158.
doi: 10.1007/s00534-006-1110-8 URL |
[26] |
MIYAZAKI M, KATO A, ITO H, et al. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?[J]. Surgery, 2007, 141(5):581-588.
doi: 10.1016/j.surg.2006.09.016 URL |
[27] |
NOJI T, TSUCHIKAWA T, OKAMURA K, et al. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching[J]. J Hepatobiliary Pancreat Sci, 2016, 23(7):442-448.
doi: 10.1002/jhbp.v23.7 URL |
[28] |
PENG C, LI C, WEN T, et al. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: a retrospective cohort study[J]. Int J Surg, 2016, 32:167-173.
doi: 10.1016/j.ijsu.2016.06.038 pmid: 27344254 |
[29] |
HU H J, JIN Y W, ZHOU R X, et al. Hepatic artery resection for bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma: is reconstruction always required?[J]. J Gastrointest Surg, 2018, 22(7):1204-1212.
doi: 10.1007/s11605-018-3711-3 |
[30] |
NAGINO M, NIMURA Y, NISHIO H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases[J]. Ann Surg, 2010, 252(1):115-123.
doi: 10.1097/SLA.0b013e3181e463a7 pmid: 20531001 |
[31] | SUGIURA T, UESAKA K, OKAMURA Y, et al. Major hepatectomy with combined vascular resection for perihilar cholangiocarcinoma[J]. BJS Open, 2021, 5(4):zrab064. |
[32] |
WU X S, DONG P, GU J, et al. Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies[J]. J Gastrointest Surg, 2013, 17(6):1107-1115.
doi: 10.1007/s11605-013-2202-9 URL |
[33] |
CHEN W, KE K, CHEN Y L. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2014, 40(5):489-495.
doi: S0748-7983(14)00310-2 pmid: 24685155 |
[34] |
GERHARDS M F, VAN GULIK T M, DE WIT L T, et al. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma-a single center experience[J]. Surgery, 2000, 127(4):395-404.
doi: 10.1067/msy.2000.104250 URL |
[35] | ABBAS S, SANDROUSSI C. Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma[J]. HPB(Oxford), 2013, 15(7):492-503. |
[36] | 陈永标, 罗晓莉, 张绍庚, 等. 超声在肝门部胆管癌术前评估中的价值[J]. 实用医学杂志, 2006, 22(20):2413-2414. |
Chen Y B, LUO X L, ZHANG S G, et al. The value of ultrasound in preoperative evaluation of hilar cholangiocarcinoma[J]. Chin J Pract Surg, 2006, 22(20):2413-2414. | |
[37] |
MASSELLI G, MANFREDI R, VECCHIOLI A, et al. MR imaging and MR cholangiopancreatography in the pre-operative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings[J]. Eur Radiol, 2008, 18(10):2213-2221.
doi: 10.1007/s00330-008-1004-z URL |
[38] |
OLIVEIRA I S, KILCOYNE A, EVERETT J M, et al. Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management[J]. Abdom Radiol (NY), 2017, 42(6):1637-1649.
doi: 10.1007/s00261-017-1094-7 pmid: 28271275 |
[39] |
RUYS A T, VAN BEEM B E, ENGELBRECHT M R, et al. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Br J Radiol, 2012, 85(1017):1255-1262.
doi: 10.1259/bjr/88405305 pmid: 22919007 |
[40] | 李连海, 许惠玲, 王金榜. 肝脏CT三维重建评估肝门部胆管癌根治术临床应用研究[J]. 实用肝脏病杂志, 2018, 21(6):947-950. |
Li L H, XU H L, WANG J B. Evaluation by CT three dimensional reconstruction in patients with hilar cholangiocarcinoma underwent hepatectomy[J]. J Pract Hepato-logy, 2018, 21(6):947-950. | |
[41] | 中华医学会数字医学分会, 中国研究型医院学会数字智能化外科专业委员会, 中华医学会外科学分会胆道外科学组, 等. 肝门部胆管癌三维可视化精准诊治中国专家共识(2019版)[J]. 中国实用外科杂志, 2020, 40(3):260-266. |
Digital Medicine of Chinese Medical Association, Digital Intelligent Surgery Professional Committee of Chinese Research Hospital Association, Branch of Biliary Surgery, Chinese Society of Surgery, Chinese Medical Association, et al. Chinese expert consensus of precise diagnosis and treatment for hilar cholangiocarcinoma using three-dimensional visualization technology (2019 edition)[J]. Chin J Prac Surg, 2020, 40(3):260-266. | |
[42] | 耿云平, 任悠悠, 李真真, 等. CT三维重建在肝门部胆管癌切除术前评估中的价值[J]. 中国现代普通外科进展, 2022, 25(6):467-469. |
GENG Y P, REN Y Y, LI Z Z, et al. Value of three-dimensional CT reconstruction in preoperative evaluation of hilar cholangiocarcinoma[J]. Chin J Curr Adv Gen Surg, 2022, 25(6):467-469. | |
[43] |
RIBERO D, AMISANO M, LO TESORIERE R, et al. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma[J]. Ann Surg, 2011, 254(5):776-781; discussion 781-783.
doi: 10.1097/SLA.0b013e3182368f85 pmid: 22042470 |
[44] |
OHWADA S, HAMADA K, KAWATE S, et al. Left renal vein graft for vascular reconstruction in abdominal malignancy[J]. World J Surg, 2007, 31(6):1215-1220.
pmid: 17453283 |
[45] |
SERRABLO A, SERRABLO L, ALIKHANOV R, et al. Vascular resection in perihilar cholangiocarcinoma[J]. Cancers (Basel), 2021, 13(21):5278
doi: 10.3390/cancers13215278 URL |
[46] |
BHANGUI P, SALLOUM C, LIM C, et al. Portal vein arterialization: a salvage procedure for a totally de-arteria-lized liver. The Paul Brousse Hospital experience[J]. HPB (Oxford), 2014, 16(8):723-738.
doi: 10.1111/hpb.12200 URL |
[1] | 朱斯维, 尹新民. 腹腔镜肝门部胆管癌根治术的现状与思考[J]. 外科理论与实践, 2023, 28(02): 100-103. |
[2] | 张梦茵, 陈平, 袁晓琴, 蔡波尔, 吴云林. 内镜下组织黏合剂联合硬化剂注射治疗胃静脉曲张临床研究及随访[J]. 外科理论与实践, 2022, 27(05): 443-447. |
[3] | 陈晓娟, 张雯, 蔡瑜. 经导管脾动脉栓塞术治疗胰源性门静脉高压致消化道出血(附1例报告)[J]. 外科理论与实践, 2022, 27(04): 359-362. |
[4] | 任家俊, 陈拥军. 肝脾联合切除治疗原发性肝癌合并门静脉高压及脾功能亢进[J]. 外科理论与实践, 2022, 27(02): 139-144. |
[5] | 张希昊, 章馨允, 曹曼卿, 张金梁, 王华琪, 张苏, 付周, 王鲁, 张倜. 肝细胞癌的抗血管生成免疫联合介入治疗:肝动脉灌注化疗与化疗栓塞疗效的比较[J]. 外科理论与实践, 2022, 27(02): 152-157. |
[6] | 张斌, 吴志勇. 门静脉高压症食管胃底静脉曲张出血的个体化治疗和手术方式选择[J]. 外科理论与实践, 2021, 26(03): 185-188. |
[7] | 孙隆慈, 张斌. 门静脉海绵样变致食管胃底静脉曲张的手术治疗(附1例报告)[J]. 外科理论与实践, 2021, 26(03): 226-230. |
[8] | 李涛, 陈皓. 肝硬化门静脉高压症的肝移植治疗[J]. 外科理论与实践, 2021, 26(03): 189-194. |
[9] | 罗蒙, 李泓杰, 郑磊. 肝硬化门静脉高压症发病机制的研究现状[J]. 外科理论与实践, 2021, 26(03): 195-198. |
[10] | 曾宁, 方驰华. 数字智能化诊疗技术在门静脉高压症中的应用[J]. 外科理论与实践, 2021, 26(03): 199-202. |
[11] | 胡明礼, 王绮夏, 马雄. 肝硬化食管胃底静脉曲张的药物治疗[J]. 外科理论与实践, 2021, 26(03): 203-207. |
[12] | 陈炜, 卜俊峰. 肝功能评估方式及在门静脉高压症围术期的应用[J]. 外科理论与实践, 2021, 26(03): 212-216. |
[13] | 杨涛, 阴继凯, 鲁建国. 腹腔镜技术在门静脉高压症外科手术中的前景[J]. 外科理论与实践, 2021, 26(03): 217-220. |
[14] | 崔然, 叶伦河, 王旭菁, 王永坤, 张琪祺, 王恺京, 王明, 戴陈新, 杨鹿笛, 董春秀, 陈波. 腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症的近期临床结果[J]. 外科理论与实践, 2021, 26(03): 221-225. |
[15] | 李敬东, 朱建交, 张立鑫, 熊永福. 肝门部胆管癌腹腔镜手术根治性切除的争议与共识[J]. 外科理论与实践, 2021, 26(02): 115-119. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||